Press Releases
-
Post-Authorization Study Develops Into Crucial Part of Drug Development Design
BERLIN, GERMANY - Apr 20, 2016 - Post-authorization safety studies (PASS) are becoming an integral part of the medicines development. Planning the design of PASS in the early phases of a clinical trial will translate into significant time- and cost-efficiency of pre-approval research
Apr 20, 2016
-
Rho to Highlight Clinical Trial Expertise, Recruit New Team Members During ACRP 2016 Global Conference
CHAPEL HILL, NC - Apr 12, 2016 - Rho, a full-service contract research organization (CRO), is hiring a number of clinical research positions and will be looking to meet potential applicants in the field at the Association of Clinical Research Professionals (ACRP) during the groups 2016 Global Conference, being held April 16-19 in Atlanta, Georgia
Apr 12, 2016
-
Certara Launches the SIVA Toolkit 2.0 to Improve Analysis of In Vitro Drug Development Data
PRINCETON, NJ - Apr 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched the Simcyp In Vitro (Data) Analysis (SIVA) Toolkit 2
Apr 12, 2016
-
ANT Neuro announces cooperation with MAG & More in high-performance rTMS stimulators.
ENSCHEDE, N/A, THE NETHERLANDS - Apr 6, 2016 - ANT Neuro b.v., part of neuromotion b.v., is pleased to announce its cooperation with MAG & More GmbH in offering high performance, top of the range navigated TMS solutions for the advanced applications in research and clinical care
Apr 5, 2016
-
CSM Announces Promotion of Brian Swites to President
FARGO, ND - Apr 4, 2016 - CSM, a leading clinical trial supply company, today announced the promotion of Brian Swites to President, effective immediately
Apr 1, 2016
-
WIRB-Copernicus Group Establishes WCG Gene Therapy Advisory Board
PRINCETON, NJ - Mar 29, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that it has assembled a team of world-renowned experts to advise the company regarding the latest advances in gene therapy research
Mar 29, 2016
-
Certara’s Synchrogenix Division Provides Unique Technology Solution, Enabling Biopharma Companies to Comply with EMA Policy 70
PRINCETON, NJ - Mar 24, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced that its regulatory and medical consultancy, Synchrogenix, has introduced an artificial intelligence- (AI-) enabled solution to meet the data transparency requirements of the clinical and drug development market
Mar 24, 2016
-
WIRB-Copernicus Group Chief Medical Officer Explores Surgical Innovation Oversight in Academic Surgery Departments
PRINCETON, NJ - Mar 22, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that the surgical innovation and oversight survey conducted by its Chief Medical Officer and President of Consulting Services Lindsay McNair, MD, MPH, MSB, and co-author Walter L
Mar 22, 2016
-
ERT Recognized with Fourth Consecutive Outstanding Customer Service Award
PHILADELPHIA, PA, UNITED STATES - Mar 21, 2016 - ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, today announced it has received Omega Management Group Corp
Mar 21, 2016
-
Joe Martinez to Join Center Point Clinical Services as Chief Executive Officer
MINNETONKA, MN - Mar 17, 2016 - Center Point Clinical Services LLC announced today that it has appointed Joe Martinez as Chief Executive Officer
Mar 17, 2016
-
“The importance of the data does not change” - Interview with Joette Keen, KCR’s Head of Biometrics and Clinical Trial Data Execution Systems (BMX)
, GERMANY - Mar 15, 2016 - Berlin - 15 March 2016 - KCR's Joette Keen talks about her transition to CRO, after spending years in pharma, and how does she see data management role in the ever-changing clinical trials worldx
Mar 15, 2016
-
Clinical Research Services Provider Clintrax Global Joins WIRB-Copernicus Group
PRINCETON, NJ - Mar 9, 2016 - WIRB-Copernicus Group® (WCG), one of the world's leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that Clintrax Global has joined its family of companies
Mar 9, 2016
-
Rho Supports Follow-up Study Demonstrating Benefit of Early Peanut Consumption is Maintained Following One Year of Peanut Avoidance
CHAPEL HILL, NC, UNITED STATES - Mar 4, 2016 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, is part of a newly published clinical trial that found that children who consumed peanut-containing foods regularly from infancy to age five and then avoided peanut for one year did not become allergic to peanut
Mar 4, 2016
-
DrugDev and Exostar Collaborate to Streamline and Secure Clinical Trial Process by Linking Exostar Identity Credential with the DrugDev Golden Number
KING OF PRUSSIA PA AND HERNDON VA, PA, UNITED STATES - Mar 2, 2016 - DrugDev and Exostar took a major step today in helping the pharma and CRO industry improve and secure clinical trial master data management as the two companies announced they will combine the power of their unique global identifiers for clinical operations personnel and facilities
Mar 2, 2016
-
WIRB-Copernicus Group Helps Develop Ethics Tool Kit for Clinical Research Protocols; Resulting Product Published in Journal of Medical Ethics
PRINCETON, NJ - Mar 2, 2016 - WIRB-Copernicus Group® (WCG), the world's largest provider of regulatory and ethical review services and software to support clinical research, today announced the publication of an innovative Ethics Tool Kit in the Journal of Medical Ethics
Mar 2, 2016
-
Cypralis Limited Announces Appointment of Dr Michael Peel as Chief Scientific Officer
ONGAR, UNITED KINGDOM - Mar 2, 2016 - Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases), has appointed Dr Michael Peel as Chief Scientific Officer
Mar 2, 2016
-
Certara Introduces Phoenix Technology Services to Optimize Pharma R&D Productivity
PRINCETON, NJ - Feb 25, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced the introduction of Phoenix® Technology Services
Feb 25, 2016
-
OPKO's GeneDx Participating in the Molecular Medicine Tri-Conference 2016 in San Francisco
MIAMI, FL, UNITED STATES - Feb 24, 2016 - OPKO Health, Inc. (NYSE: OPK) announced today that GeneDx was invited to participate in the Molecular Medicine Tri-Conference 2016, being held at the Moscone North Convention Center in San Francisco, California from March 6th - 11th, 2016, and will also be exhibiting at Booth 606
Feb 24, 2016
-
DrugDev Launches Clinical Site Activation SaaS Technology as Key Part of Its Unified Platform to Reduce the Time of Startup from Months to Weeks
KING OF PRUSSIA, PA, UNITED STATES - Feb 22, 2016 - DrugDev continues to add innovative technology features to its award-winning platform for clinical trial optimization with its new site activation module, which can reduce startup time from months to weeks
Feb 21, 2016
-
Rho Experts to Speak at the 2016 SCOPE Summit
CHAPEL HILL, NC, UNITED STATES - Feb 19, 2016 - WHAT: Rho, a full-service contract research organization (CRO), will speak on post lock data flow at the 2016 SCOPE Summit, taking place on February 23-25 in Miami, Florida
Feb 19, 2016
